Barbara Mintzes

Summary

Affiliation: University of British Columbia
Country: Canada

Publications

  1. ncbi Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy
    Barbara Mintzes
    Centre for Health Services and Policy Research, University of British Columbia UBC, Vancouver, BC Canada V6T 1Z3
    Res Social Adm Pharm 1:310-30. 2005
  2. ncbi Pfizer conducts survey of French patients on information provided by industry
    Barbara Mintzes
    BMJ 334:1027. 2007
  3. ncbi Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale
    Barbara Mintzes
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada Barbara Mintzes
    PLoS ONE 4:e5699. 2009
  4. ncbi Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey
    Barbara Mintzes
    Centre for Health Services and Policy Research, University of British Columbia, Vancouver BC, Canada V6T 1Z3
    BMJ 324:278-9. 2002
  5. ncbi Disease mongering in drug promotion: do governments have a regulatory role?
    Barbara Mintzes
    Therapeutics Initiative, Department of Anaesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada
    PLoS Med 3:e198. 2006
  6. ncbi How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA
    Barbara Mintzes
    Centre for Health Services and Policy Research, and the Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC
    CMAJ 169:405-12. 2003
  7. ncbi Should patient groups accept money from drug companies? No
    Barbara Mintzes
    Therapeutics Initiative and Health Action International HAI Europe, 2176 Health Sciences Mall, Vancouver BC, V6T 1Z3 Canada
    BMJ 334:935. 2007
  8. ncbi For and against: Direct to consumer advertising is medicalising normal human experience: For
    Barbara Mintzes
    Centre for Health Services and Policy Research, University of British Columbia, 429-2194 Health Services Mall, Vancouver, BC, Canada V6T 1Z3
    BMJ 324:908-9. 2002
  9. ncbi An outcomes-based approach to decisions about drug coverage policies in British Columbia
    Steve Morgan
    Program in Pharmaceutical Policy, Centre for Health Services and Policy Research, University of British Columbia, 429-2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
    Psychiatr Serv 55:1230-2. 2004
  10. ncbi The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Steven Morgan
    Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, V6T 1Z3, Canada
    J Health Serv Res Policy 8:237-44. 2003

Detail Information

Publications31

  1. ncbi Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy
    Barbara Mintzes
    Centre for Health Services and Policy Research, University of British Columbia UBC, Vancouver, BC Canada V6T 1Z3
    Res Social Adm Pharm 1:310-30. 2005
    ..This article describes a survey of Canadian drug policy experts carried out in 2001, during one such legislative review. The survey results are compared to more recent DTCA policy developments...
  2. ncbi Pfizer conducts survey of French patients on information provided by industry
    Barbara Mintzes
    BMJ 334:1027. 2007
  3. ncbi Twelve years' experience with direct-to-consumer advertising of prescription drugs in Canada: a cautionary tale
    Barbara Mintzes
    Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, Canada Barbara Mintzes
    PLoS ONE 4:e5699. 2009
    ..We ask how annual per capita spending compares to that in the US, and whether drugs with Canadian or US regulatory safety warnings are advertised to the Canadian public in reminder advertising...
  4. ncbi Influence of direct to consumer pharmaceutical advertising and patients' requests on prescribing decisions: two site cross sectional survey
    Barbara Mintzes
    Centre for Health Services and Policy Research, University of British Columbia, Vancouver BC, Canada V6T 1Z3
    BMJ 324:278-9. 2002
  5. ncbi Disease mongering in drug promotion: do governments have a regulatory role?
    Barbara Mintzes
    Therapeutics Initiative, Department of Anaesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada
    PLoS Med 3:e198. 2006
  6. ncbi How does direct-to-consumer advertising (DTCA) affect prescribing? A survey in primary care environments with and without legal DTCA
    Barbara Mintzes
    Centre for Health Services and Policy Research, and the Department of Pharmacology and Therapeutics, University of British Columbia, Vancouver, BC
    CMAJ 169:405-12. 2003
    ..We compared prescribing decisions in a US setting with legal DTCA and a Canadian setting where DTCA of prescription drugs is illegal, but some cross-border exposure occurs...
  7. ncbi Should patient groups accept money from drug companies? No
    Barbara Mintzes
    Therapeutics Initiative and Health Action International HAI Europe, 2176 Health Sciences Mall, Vancouver BC, V6T 1Z3 Canada
    BMJ 334:935. 2007
  8. ncbi For and against: Direct to consumer advertising is medicalising normal human experience: For
    Barbara Mintzes
    Centre for Health Services and Policy Research, University of British Columbia, 429-2194 Health Services Mall, Vancouver, BC, Canada V6T 1Z3
    BMJ 324:908-9. 2002
  9. ncbi An outcomes-based approach to decisions about drug coverage policies in British Columbia
    Steve Morgan
    Program in Pharmaceutical Policy, Centre for Health Services and Policy Research, University of British Columbia, 429-2194 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3
    Psychiatr Serv 55:1230-2. 2004
  10. ncbi The economics of direct-to-consumer advertising of prescription-only drugs: prescribed to improve consumer welfare?
    Steven Morgan
    Centre for Health Services and Policy Research, University of British Columbia, 429 2194 Health Sciences Mall, Vancouver, V6T 1Z3, Canada
    J Health Serv Res Policy 8:237-44. 2003
    ....
  11. ncbi Medicine by media: did a critical television documentary affect the prescribing of cyproterone--estradiol (Diane-35)?
    Barbara Mintzes
    Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC
    CMAJ 173:1313-5. 2005
  12. ncbi Prescription drug use in pregnancy: a retrospective, population-based study in British Columbia, Canada (2001-2006)
    Jamie R Daw
    Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada
    Clin Ther 34:239-249.e2. 2012
    ..Owing to the paucity of evidence available on the risks and benefits of drug use in pregnancy, the use of prescription medicines is a concern for both pregnant women and their health care providers...
  13. ncbi Outcomes-based drug coverage in British Columbia
    Steven Morgan
    University of British Columbia, Health Care and Epidemiology, Program in Pharmaceutical Policy, Centre for Health Services and Policy Research
    Health Aff (Millwood) 23:269-76. 2004
    ..We describe lessons from the B.C. experience for jurisdictions interested in basing coverage on evidence of proven comparative advantage for patients' health...
  14. ncbi Advertising of prescription-only medicines to the public: does evidence of benefit counterbalance harm?
    Barbara Mintzes
    Therapeutics Initiative, Department of Anesthesiology, Pharmacology and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada
    Annu Rev Public Health 33:259-77. 2012
    ..There is no evidence of improved treatment quality or early provision of needed care. If policy is to be informed by evidence, the strength of research methods and ability to assess causality need to be considered...
  15. ncbi Too much disclosure of product risks? CBC television, SOGC, and Diane-35
    Barbara Mintzes
    Centre for Health Services and Policy Research, University of British Columbia, Vancouver, BC, Canada
    J Obstet Gynaecol Can 25:268-9; discussion 270-3. 2003
  16. ncbi Direct-to-consumer advertising of prescription medicines: a counter argument
    Barbara Mintzes
    Therapeutics Initiative, University of British Columbia, 2176 Health Services Mall, Vancouver, BC, V6T 1Z3, Canada
    Future Med Chem 1:1555-60. 2009
    ..b>Barbara Mintzes and Dee Mangin provide their case against direct-to-consumer advertising of prescription medicines, arguing ..
  17. ncbi The sources and popularity of online drug information: an analysis of top search engine results and web page views
    Michael R Law
    Centre for Health Services and Policy Research, School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada
    Ann Pharmacother 45:350-6. 2011
    ..The Internet has become a popular source of health information. However, there is little information on what drug information and which Web sites are being searched...
  18. ncbi Direct-to-consumer prescription drug advertising in Canada: permission by default?
    David M Gardner
    Department of Psychiatry and the College of Pharmacy, Dalhousie University, Halifax, NS
    CMAJ 169:425-7. 2003
  19. ncbi Medicine reimbursement recommendations in Canada, Australia, and Scotland
    Joel Lexchin
    School of Health Policy and Management, York University, 4700 Keele St, Toronto, Ontario, Canada M3J 1P3
    Am J Manag Care 14:581-8. 2008
    ....
  20. ncbi Direct-to-consumer advertising is more profitable if it is misleading
    Peter R Mansfield
    Director, Healthy Skepticism, Willunga, SA, Australia
    N Z Med J 116:U610. 2003
  21. ncbi Direct to consumer advertising of prescription drugs
    Barbara Mintzes
    BMJ 337:a985. 2008
  22. ncbi Transparency in drug regulation: mirage or oasis?
    Joel Lexchin
    Emergency Department, University Health Network, School of Health Policy and Management, York University, Toronto, Ont
    CMAJ 171:1363-5. 2004
  23. ncbi Do higher drug costs lead to better health?
    Barbara Mintzes
    Can J Clin Pharmacol 12:e22-7. 2005
    ..For "newer" to truly mean "better", fundamental changes are needed to the regulations governing market approval and post-approval surveillance. Such changes are possible, but would require strong political will...
  24. ncbi Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs
    Alan Cassels
    School of Health Information Science, University of Victoria, Victoria, BC
    CMAJ 168:1133-7. 2003
    ..We assessed newspaper descriptions of drug benefits and harms, the nature of the effects described and the presence or absence of other important information that can add context and balance to a report about a new drug...
  25. ncbi Direct to consumer advertising
    Peter R Mansfield
    BMJ 330:5-6. 2005
  26. ncbi Antidepressants and adverse effects in young patients: uncovering the evidence
    Andrew Herxheimer
    Cochrane Collaboration, London, England
    CMAJ 170:487-9. 2004
  27. ncbi Drug safety without borders: concerns about bupropion
    Barbara Mintzes
    CMAJ 167:447. 2002
  28. ncbi Should paroxetine be used to treat depression during pregnancy?
    Barbara Mintzes
    Am J Psychiatry 165:1487; author reply 1487-8. 2008
  29. ncbi Does direct-to-consumer advertising of antidepressants lead to a net social benefit?
    Jon Jureidini
    Women s and Children s Hospital, North Adelaide, SA, Australia
    Pharmacoeconomics 26:557-66; discussion 567-8. 2008
  30. ncbi Medications for obesity
    Joel Lexchin
    Can Fam Physician 54:848-9; author reply 849-50. 2008
  31. ncbi Questions about Adderall XR
    Pierre Biron
    CMAJ 174:1303-4. 2006